Objective: The aim of this study was to determine the prevalence of micro- or macroalbuminuria in type 1 and type 2 diabetic patients, and to examine the relationship with the diabetes control parameters such as haemoglobin (Hb)A1c, blood pressure (BP) and lipids.Design: This was an analytical cross-sectional study.Setting and subjects: The study consisted of 754 patients with either type 1 or type 2 diabetes, attending a diabetes clinic at the Kalafong Hospital in Pretoria, South Africa.Outcome measures: Micro- or macroalbuminuria and estimated glomerular filtration rate (eGFR) were the outcome measures.Results: An HbA1c > 7% was recorded in 88.9% of the patients, and low-density lipoprotein cholesterol . 1.8 mmol/l in 81%. Overall, t...
OBJECTIVES: To determine the prevalence of microalbuminuria, macroalbuminuria and renal insufficienc...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
[[abstract]]Aims/hypothesis: Microalbuminuria represents the earliest clinical evidence of diabetic ...
Background: Microalbuminuria (MA) has been established as an early marker of both diabetic nephropat...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
Background: Albuminuria is long recognised as a sign of renal disease in diabetes. In type ...
Introduction: Microalbuminuria is the earliest clinical evidence of diabetic nephropathy. However, p...
Thesis (MMed)--Stellenbosch University, 2011.Background: The epidemic of type 2 diabetes poses an en...
Background: Microalbuminuria is an earliest marker of overt diabetic nephropathy, hence monitoring m...
Background: diabetes mellitus and its complications is one of the major health problems. ...
Type 2 diabetes mellitus (T2DM) is an alarming health care concern the world over affecting more-tha...
Background: Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy, and ...
This cross-sectional community-based study was carried out to determine the prevalence of microalbum...
Aim: Microalbuminuria (MAU) has been shown to be a risk factor for nephropathy in patients with type...
OBJECTIVES: To determine the prevalence of microalbuminuria, macroalbuminuria and renal insufficienc...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
[[abstract]]Aims/hypothesis: Microalbuminuria represents the earliest clinical evidence of diabetic ...
Background: Microalbuminuria (MA) has been established as an early marker of both diabetic nephropat...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
Background: Albuminuria is long recognised as a sign of renal disease in diabetes. In type ...
Introduction: Microalbuminuria is the earliest clinical evidence of diabetic nephropathy. However, p...
Thesis (MMed)--Stellenbosch University, 2011.Background: The epidemic of type 2 diabetes poses an en...
Background: Microalbuminuria is an earliest marker of overt diabetic nephropathy, hence monitoring m...
Background: diabetes mellitus and its complications is one of the major health problems. ...
Type 2 diabetes mellitus (T2DM) is an alarming health care concern the world over affecting more-tha...
Background: Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy, and ...
This cross-sectional community-based study was carried out to determine the prevalence of microalbum...
Aim: Microalbuminuria (MAU) has been shown to be a risk factor for nephropathy in patients with type...
OBJECTIVES: To determine the prevalence of microalbuminuria, macroalbuminuria and renal insufficienc...
Background: The prevalences and risk factors of microalbuminuria are not full described among black ...
[[abstract]]Aims/hypothesis: Microalbuminuria represents the earliest clinical evidence of diabetic ...